ARC is enrolling patients for clinical studies

Austin Regional Clinic (ARC) doctors and advanced practice clinicians (APCs) find value in what we can learn from clinical research. In partnership with Innovo Research, Austin Regional Clinic is now accepting applicants for two studies related to chronic kidney disease (CKD).

Enrollment in a study not only helps advance medical science, but also gives you access to specialized care and trial medications which may not be available outside a research study. Your decision to enter a study is optional and does not interfere with your medical care at ARC. If you are eligible and accepted for enrollment in a clinical trial, you may also receive compensation for your time.

All medications, lab tests, and health evaluations are provided at no cost to you or your insurance. During the study, you will also receive study-related care provided by the research physician, nurse, and staff.

Current enrolling studies:

• BaxDuo Arctic Chronic Kidney Disease (CKD) and Hypertension (HTN) Study: This study is testing for patient response and tolerance to taking both dapagliflozin and the trial drug, baxdrostat in participants with chronic kidney disease (CKD) and high blood pressure.
• Clinical Biospecimen Collection for Alzheimer's and Parkinson's Disease Biomarker Research: A study to collect specimens from subjects with Alzheimer's or Parkinson's for the purpose of biobanking and commercial use towards biomarker development and other technologies or treatments.
• ENABLE Multiple Sclerosis (MS) Study: A long-term observational registry study to collect real world data on BRIUMVI efficacy, safety, and tolerability.
• Zenith Chronic Kidney Disease (CKD) and Proteinuria Study: AstraZeneca researchers are investigating whether the trial drug, zibotentan combined with dapagliflozin, could help treat CKD and high proteinuria.

Visit our enrolling studies page for more information.

If you would like to participate in a study, please call 737-247-7200 and press "9".